"Standard Treatment Guidelines are a necessary but insufficient condition for integrating Ayush into mainstream healthcare." Critically examine.

The Ministry of Ayush has released Standard Treatment Guidelines (STGs) on dermatological disorders. They cover Ayurveda, Siddha, Unani, Homoeopathy and Yoga, and were prepared by the Ayush Vertical of DGHS [1]. STGs are the foundation for integration. But integration also needs evidence, drug safety, infrastructure and financing.

Why STGs are necessary

• Uniformity and accountability: One written protocol for prevention, diagnosis, treatment and follow-up replaces each practitioner's own style. It was field-validated with Delhi Medical Officers [1].
• Testability: Outcome studies can test a named protocol for psoriasis or vitiligo. They cannot test "whatever each doctor does". STGs make research possible.
• Insurance linkage: Ayush hospitals were urged to adopt STGs with ICD-TM2 codes for empanelment [2]. STGs are also building blocks for Ayush packages under PM-JAY [3].
• Convergence: Parliament wants disease-wise protocols in allopathy too [4], so STGs bring Ayush under the same rule as modern medicine.

Why they are insufficient

• Evidence gap: The STGs are "evidence-informed", built from classical texts and expert consensus. They are not RCT-validated [1]. A government seal may make an unproven treatment look proven.
• Drug quality: An STG controls the prescription, not what is inside the bottle. A Parliamentary Standing Committee flagged high metal content in Ayush drugs and sought post-marketing surveillance [5].
• Weak pharmacovigilance: Since 2018, only 1,637 ADR reports have been recorded against 32,527 misleading advertisements [6]. The Ayush Suraksha portal came only after a Supreme Court order in WP(C) 645/2022 [7].
• Infrastructure deficit: Over 69% of approved integrated Ayush hospitals are still under construction, and only 65% of Ayush HWCs have been set up [5]. Health is a State subject, so the Delhi pilot will not spread by itself.

STGs give Ayush a common language. Proof of safety and efficacy has to come from elsewhere. The way forward:

• Research Councils should run outcome studies on these protocols.
• STG-based prescriptions should feed ADR data into Ayush Suraksha [7].
• PM-JAY packages should be priced on STGs, with adherence audits [3][4].
• States should repeat the Delhi field validation [1].

This would make STGs the first step of a full evidence chain and serve the Article 47 duty to improve public health. STGs are necessary but not sufficient. Integration will be real only when standard protocols are matched by standard proof.